GlassScriptPhysician profile
Alfredo T Ermac
NPI 1649268384
$8,899.29
in general payments reported to CMS, 2019-2025
55 companies · $540 in 2025
The $540 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,362 · 2020: $808 · 2021: $1,230 · 2022: $1,649 · 2023: $1,979 · 2024: $1,331 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,850.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,097.54 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,321.83 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $656.91 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $424.99 | 2019-2024 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $415.09 | 2019-2024 | |
| Lilly USA, LLC | $333.36 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Corium, LLC | $269.50 | 2022-2024 | Azstarys |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $224.34 | 2019-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $215.94 | 2022-2024 | |
| Biohaven Pharmaceuticals, INC. | $207.86 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $205.31 | 2020-2024 | Trintellix |
| Allergan, INC. | $201.65 | 2019-2020 | |
| Abbott Laboratories | $172.24 | 2022-2024 | Freestyle Libre 3, Proclaim |
| Merck Sharp & Dohme LLC | $157.07 | 2019-2023 | Belsomra |
| Glaxosmithkline, LLC. | $134.47 | 2022-2024 | Arexvy, Shingrix, Trelegy Ellipta |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfredo Ermac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.